Melanocortin 4 Receptor Agonist
- Name
- Melanocortin 4 Receptor Agonist
- Accession Number
- DBCAT005511
- Description
Not Available
- Drugs
Drug Drug Description Setmelanotide Setmelanotide is indicated to treat obesity caused by genetic POMC, PCSK1, or LEPR deficiencies or Bardet-Biedl syndrome. - Drugs & Drug Targets
Drug Target Type Setmelanotide Melanocortin receptor 4 target